REG - CVS Group plc - CMA Update

CVSAnnouncement

18/02/2022 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220218:nRSR1164Ca&default-theme=true

RNS Number : 1164C  CVS Group plc  18 February 2022

18 February 2022

 

CVS Group plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

 

 CMA Update

 

CVS, one of the UK's leading providers of integrated veterinary services,
notes that the Competition and Markets Authority ("CMA") has published the
findings of its phase one investigation of the completed acquisition by CVS of
Quality Pet Care Ltd (trading as The Vet) (the "Acquisition")(1).  The CMA
has decided that the Acquisition may have resulted in a substantial lessening
of competition ("SLC") in five locations, namely Bristol, Nottingham,
Portsmouth, Southampton and Warrington.

 

We are naturally disappointed with this decision, and have good grounds for
believing that it would ultimately be overturned should we commit to a phase
two investigation.  We are reviewing the decision in detail before deciding
on the most appropriate course of action.  We will provide a further update
to the market in due course.

 

The board believes that this is the first case in which the CMA has assessed
local competition in the veterinary sector.  While we recognise that the CMA
will assess each case on its merits, we nonetheless believe that the
understanding gained as to the basis of assessment used by the CMA in this
particular case will be helpful in the Group's own appraisal of a number of
future acquisition opportunities in the UK.

 

CVS acquired Quality Pet Care Ltd, a small group of first opinion practices
trading as The Vet and operating from eight practice locations in the UK, in
August 2021 for consideration of £20.4m.  The financial statements of
Quality Pet Care Ltd, filed at Companies House(2) for its financial year ended
31 March 2021, show that these eight practices generated combined revenue of
£11.3m for that financial year.

 

CVS operates 467 other veterinary practices in the UK (excluding The Vet) and
the Group's Practices division generated revenue of £453.4m in the financial
year to 30 June 2021 (prior to the acquisition of The Vet).

 

The latest data from the Royal College of Veterinary Surgeons shows that there
are c.5,300 registered veterinary practices in the UK and hence CVS has a c.9%
share of UK veterinary practices by number.

 

Outlook

The board of CVS remains confident in the future growth prospects of the Group
and will provide further detail on current trading and the outlook for the
full year when it publishes the Group's interim financial results for the six
month period ended 31 December 2021 on 24 March 2022.

 

Notes

1        See CMA published findings at
https://www.gov.uk./cma-cases/cvs-slash-quality-pet-care-merger-inquiry
(https://www.gov.uk./cma-cases/cvs-slash-quality-pet-care-merger-inquiry)

2        See Quality Pet Care Ltd Companies House filings at QUALITY
PET CARE LTD filing history - Find and update company information - GOV.UK
(company-information.service.gov.uk)
(https://find-and-update.company-information.service.gov.uk/company/08249167/filing-history)

 

 

 Contacts:

 CVS Group plc                                                                                    via MHP Communications
 Richard Fairman, CEO
 Robin Alfonso, CFO
 Ben Jacklin, COO

 Singer Capital Markets (Nominated Adviser & Broker)                                              +44 20 7496 3000

 Aubrey Powell / Rachel Hayes / Jen Boorer
 MHP Communications (Financial PR)                                                                +44 20 3128 8549
 Andrew Jaques / Simon Hockridge / Rachel Mann / Charles Hirst

 

Notes to Editors

CVS Group is a fully integrated provider of veterinary services in the UK,
with practices in the Netherlands and the Republic of Ireland.  CVS is
focused on providing high quality clinical services to its customers and their
animals, with outstanding and dedicated clinical teams and support colleagues
at the core of its strategy.

The Group has c.500 veterinary practices across its three markets, including
eight specialist referral hospitals and 35 dedicated out-of-hours sites.
 Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and third party
practices), Buying Groups and the Group's online retail business (Animed
Direct).

The Group employs c.7,900 personnel, including c.2,000 veterinary surgeons and
c.2,800 nurses.

Further information is available via the Company's website, at
www.cvsukltd.co.uk (http://www.cvsukltd.co.uk)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSFFSWAEESEFE